Standardized classification schemes in reporting oncologic PET/CT

The imaging report is essential for the communication between physicians in patient care. The information it contains must be clear, concise with evidence-based conclusions and sufficient to support clinical decision-making. In recent years, several classification schemes and/or reporting guidelines...

Descripción completa

Detalles Bibliográficos
Autores principales: Murad, Vanessa, Kulanthaivelu, Roshini, Ortega, Claudia, Veit-Haibach, Patrick, Metser, Ur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9909469/
https://www.ncbi.nlm.nih.gov/pubmed/36777163
http://dx.doi.org/10.3389/fmed.2022.1051309
Descripción
Sumario:The imaging report is essential for the communication between physicians in patient care. The information it contains must be clear, concise with evidence-based conclusions and sufficient to support clinical decision-making. In recent years, several classification schemes and/or reporting guidelines for PET have been introduced. In this manuscript, we will review the classifications most frequently used in oncology for interpreting and reporting (18)F-FDG PET imaging in lymphoma, multiple myeloma, melanoma and head and neck cancers, PSMA-ligand PET imaging for prostate cancer, and (68)Ga-DOTA-peptide PET in neuroendocrine tumors (NET).

Ejemplares similares